Reimagining Coronary Care: the Evolution of Anatomy, Physiology, and Plaque
In this discussion, Drs. Michael Gibson and Malissa Wood discuss the transformative role of coronary CTA (CCTA) in today’s cardiology landscape, shifting the focus from simply identifying arterial narrowing to a comprehensive understanding of a patient’s vessel wall and overall disease burden.
"We have moved away from just being ‘plumbers’ looking at the narrowing of the lumen, to now looking at the wall, what’s in that plaque, and finally, the functional assessment of how all this affects coronary blood flow." — Dr. Michael Gibson
Drs. Gibson and Wood explore how integrating anatomical insights with AI-driven plaque analysis and FFRCT physiology provides a “fully functional assessment” previously unattainable through non-invasive means.
By leveraging advanced imaging to visualize what is happening within the vessel wall, clinicians can move beyond “eyeball” reads and traditional risk stratification to precisely identify patients who require aggressive intervention, such as bypass surgery or intensive lipid-lowering therapies. Empowering physicians to treat CAD with a newfound level of precision.
These insights underscore a new standard of care where CAD is managed as a measurable, stageable condition, ensuring that the right patients receive the right care at the right time.
See CAD. Manage for life.
